NYSEAMERICAN : XTNT
Xtant Medical Holdings, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 0.2802 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 39.31M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 39.06M |
| Enterprise Value | 55.20M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 140.29M |
| Shares Outstanding | 140.29M |
| Shares Change (YoY) | +1.38% |
| Shares Change (QoQ) | +0.14% |
| Owned by Insiders (%) | 12.63% |
| Owned by Institutions (%) | 13.52% |
| Float | 54.18M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.36 |
| Forward PS | 0.37 |
| PB Ratio | 0.98 |
| P/TBV Ratio | 1.17 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 68.91 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.51 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.16 |
| Quick Ratio | 0.98 |
| Debt / Equity | 0.65 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.99 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -25.16% |
| Return on Assets (ROA) | -3.75% |
| Return on Invested Capital (ROIC) | -10.17% |
| Return on Capital Employed (ROCE) | -11.06% |
| Weighted Average Cost of Capital (WACC) | 5.24% |
| Revenue Per Employee | $725,344 |
| Profits Per Employee | -$73,755 |
| Employee Count | 151 |
| Asset Turnover | 1.20 |
| Inventory Turnover | 1.21 |
Taxes
| Measure | Value |
|---|
| Income Tax | 1.90M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | -0.20 |
| 52-Week Price Change | -68.35% |
| 50-Day Moving Average | 0.33 |
| 200-Day Moving Average | 0.46 |
| Relative Strength Index (RSI) | 37.22 |
| Average Volume (20 Days) | 102,833 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 300,482 |
| Short Previous Month | 268,742 |
| Short % of Shares Out | 0.21% |
| Short % of Float | 0.55% |
| Short Ratio (days to cover) | 1.66 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 109.53M |
| Gross Profit | 65.05M |
| Operating Income | -5.50M |
| Pretax Income | -9.24M |
| Net Income | -11.14M |
| EBITDA | -1.47M |
| EBIT | -5.50M |
| Loss Per Share | -$0.08 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 9.87M |
| Total Debt | 26.01M |
| Net Cash | -16.14M |
| Net Cash Per Share | -$0.12 |
| Equity (Book Value) | 40.02M |
| Book Value Per Share | 0.29 |
| Working Capital | 34.81M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 570,000 |
| Capital Expenditures | -1.27M |
| Depreciation & Amortization | 4.02M |
| Net Borrowing | -11.84M |
| Free Cash Flow | -696,000 |
| FCF Per Share | -$0.00 |
Margins
| Measure | Value |
|---|
| Gross Margin | 59.39% |
| Operating Margin | -5.02% |
| Pretax Margin | -8.44% |
| Profit Margin | -10.17% |
| EBITDA Margin | -1.34% |
| EBIT Margin | -5.02% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.38% |
| Shareholder Yield | -1.38% |
| Earnings Yield | -28.57% |
| FCF Yield | -1.77% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $1.03 |
| Price Target Difference | 271.05% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | -3.90% |
| EPS Growth Forecast (3Y) | -28.69% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Feb 14, 2018 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -1.73 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |